Summary by Moomoo AI
Pharmaceutical Union Biotechnology Co., Ltd. (“Pharmaceutical Union”) issued a voluntary notice on 7 March 2024, noting that recent unusual changes in the price and trading of the Company's shares on the Hong Kong Stock Exchange Limited have been unusual. After reasonable enquiries, the Pharmaceutical Union confirms that it is not aware of any inside information to be disclosed at this time and emphasises that the company's business and financial condition remains normal without significant changes. The Company reminds shareholders and potential investors to exercise caution when trading. The announcement was made by the Executive Director and Chief Executive Officer, Dr. Lee Kam Chai, on behalf of the Board.